Chronological Vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series
Overview
Authors
Affiliations
Aging is the gradual decline in physical and physiological functioning leading to increased susceptibility to stressors and chronic illnesses, including cardiovascular disease. With an aging global population, in which 1 in 6 individuals will be older than 60 years by 2030, interventional cardiologists are increasingly involved in providing complex care for older individuals. Although procedural aspects remain their main clinical focus, interventionalists frequently encounter age-associated risks that influence eligibility for invasive care, decision making during the intervention, procedural adverse events, and long-term management decisions. The unprecedented growth in transcatheter interventions, especially for structural heart diseases at extremes of age, have pushed age-related risks and implications for cardiovascular care to the forefront. In this JACC state-of-the-art review, the authors provide a comprehensive overview of the aging process as it relates to cardiovascular interventions, with special emphasis on the difference between chronological and biological aging. The authors also address key considerations to improve health outcomes for older patients during and after their invasive cardiovascular care. The role of "gerotherapeutics" in interventional cardiology, technological innovation in measuring biological aging, and the integration of patient-centered outcomes in the older adult population are also discussed.
Bridging Care Gaps for Older Women Undergoing Percutaneous Coronary Intervention.
Kalra K, Sampath R, Cigarroa N, Sutton N, Damluji A, Nanna M Interv Cardiol Clin. 2024; 14(1):69-79.
PMID: 39537289 PMC: 11851336. DOI: 10.1016/j.iccl.2024.08.006.
Higuchi R, Nanasato M, Hosoya Y, Isobe M Circ Rep. 2024; 6(11):505-513.
PMID: 39525297 PMC: 11541181. DOI: 10.1253/circrep.CR-24-0111.
Cholesterol Lowering in Older Adults: Should We Wait for Further Evidence?.
Jamil Y, Cohen R, Alameddine D, Deo S, Kumar M, Orkaby A Curr Atheroscler Rep. 2024; 26(9):521-536.
PMID: 38958924 DOI: 10.1007/s11883-024-01224-4.
Transgender healthcare: metabolic outcomes and cardiovascular risk.
Glintborg D, Christensen L, Andersen M Diabetologia. 2024; 67(11):2393-2403.
PMID: 38958699 DOI: 10.1007/s00125-024-06212-6.